Skip to main content
. 2023 Sep 1;15:100381. doi: 10.1016/j.jvacx.2023.100381

Table 1.

Comparison of clinical backgrounds of patients whose sequelae were ameliorated by vaccine and those were not.

Population with no recovery of sequelae after vaccination
(N = 96)
Population with recovery of sequelae after vaccination
(N = 15)
P value
Age 55.4 ± 15.5 60.1 ± 14.1 0.27
Sex(male), % 63.5 60 0.79
BMI 24.6 ± 4.8 23.6 ± 4.6 0.49
Smoker, % 14.6 6.7 0.40
Hypertension, % 33.3 40.0 0.61
Diabetes, % 22.9 13.3 0.40
Cardiovascular disease, % 3.1 6.7 0.49
Cancer, % 5.3 0 0.36
Asthma, % 5.3 6.7 0.83
COPD, % 8.4 0 0.24
Hyperuricemia, % 13.7 13.3 0.97
Chronic Liver disease, % 2.1 0 0.57
Chronic Kidney disease, % 4.3 0 0.42
Severe COVID-19, % 14.6 13.3 0.90